Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Brain-type creatine kinase BB as a potential tumour marker--serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies.

× No keyword cloud information.

8 in total

1. Serum creatine kinase isoenzyme levels in patients with cerebral tumours.

Authors: A S David
Journal: J Clin Pathol Date: 1984-11 Impact factor: 3.411

2. Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a.

Authors: R Kaddurah-Daouk; J W Lillie; G H Daouk; M R Green; R Kingston; P Schimmel
Journal: Mol Cell Biol Date: 1990-04 Impact factor: 4.272

3. The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma.

Authors: Timothy G Whitsett; Landon J Inge; Nhan L Tran
Journal: Transl Lung Cancer Res Date: 2013-12

4. Extracellular metabolic energetics can promote cancer progression.

Authors: Jia Min Loo; Alexis Scherl; Alexander Nguyen; Fung Ying Man; Ethan Weinberg; Zhaoshi Zeng; Leonard Saltz; Philip B Paty; Sohail F Tavazoie
Journal: Cell Date: 2015-01-15 Impact factor: 41.582

Review 5. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

Authors: Elsa Ghirardini; Francesco Calugi; Giulia Sagona; Federica Di Vetta; Martina Palma; Roberta Battini; Giovanni Cioni; Tommaso Pizzorusso; Laura Baroncelli
Journal: Genes (Basel) Date: 2021-07-24 Impact factor: 4.096

Brain-type creatine kinase BB as a potential tumour marker--serum levels measured by radioimmunoassay in 1015 patients with histologically confirmed malignancies.

1. Serum creatine kinase isoenzyme levels in patients with cerebral tumours.

2. Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a.

3. The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma.

4. Extracellular metabolic energetics can promote cancer progression.

Review 5. The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development.

6. Raised concentration of plasma creatine kinase BB isoenzyme in myelodysplasia.

7. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.

8. Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients.